Ionis Pharmaceuticals Inc (IONS): Revenue
$943.71M
Year ended 2025-12-31
$874.09M
Trailing 12 months to 2026-06-30
+17.1%
3-year compound annual growth
+5.3%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $943.71M | +33.8% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $705.14M | -10.5% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $787.65M | +34.1% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $587.37M | -27.5% | 2025-02-19, From 2022-01-01 |
| 2021-12-31 | $810.46M | +11.1% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $729.26M | -35.0% | 2023-02-22, From 2020-01-01 |
| 2019-12-31 | $1.12B | +87.2% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $599.67M | +16.6% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $514.18M | +37.9% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $372.78M | n/a | 2019-03-01, From 2016-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $943.71M | +33.8% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $958.40M | +432.1% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $883.37M | +43.8% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $868.45M | +21.5% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $1.07B | +11.9% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $829.45M | n/m |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $1.09B | -4.3% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $780.57M | +23.6% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $761.41M | +12.8% |
Compare IONS, MDGL, ANIP, HRMY side by side · Screen every company in Pharmaceutical Preparations ↗